236 related articles for article (PubMed ID: 29712852)
1. Revealing the specificity of regulatory T cells in murine autoimmune diabetes.
Spence A; Purtha W; Tam J; Dong S; Kim Y; Ju CH; Sterling T; Nakayama M; Robinson WH; Bluestone JA; Anderson MS; Tang Q
Proc Natl Acad Sci U S A; 2018 May; 115(20):5265-5270. PubMed ID: 29712852
[TBL] [Abstract][Full Text] [Related]
2. Reversal of established autoimmune diabetes by restoration of endogenous beta cell function.
Ryu S; Kodama S; Ryu K; Schoenfeld DA; Faustman DL
J Clin Invest; 2001 Jul; 108(1):63-72. PubMed ID: 11435458
[TBL] [Abstract][Full Text] [Related]
3. The role of islet antigen presenting cells and the presentation of insulin in the initiation of autoimmune diabetes in the NOD mouse.
Unanue ER; Ferris ST; Carrero JA
Immunol Rev; 2016 Jul; 272(1):183-201. PubMed ID: 27319351
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells targeting a pathogenic MHC class II: Insulin peptide epitope postpone spontaneous autoimmune diabetes.
Obarorakpor N; Patel D; Boyarov R; Amarsaikhan N; Cepeda JR; Eastes D; Robertson S; Johnson T; Yang K; Tang Q; Zhang L
Front Immunol; 2023; 14():1207108. PubMed ID: 37593744
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens.
Kleffel S; Vergani A; Tezza S; Ben Nasr M; Niewczas MA; Wong S; Bassi R; D'Addio F; Schatton T; Abdi R; Atkinson M; Sayegh MH; Wen L; Wasserfall CH; O'Connor KC; Fiorina P
Diabetes; 2015 Jan; 64(1):158-71. PubMed ID: 25187361
[TBL] [Abstract][Full Text] [Related]
6. Position β57 of I-A
Gioia L; Holt M; Costanzo A; Sharma S; Abe B; Kain L; Nakayama M; Wan X; Su A; Mathews C; Chen YG; Unanue E; Teyton L
Sci Immunol; 2019 Aug; 4(38):. PubMed ID: 31471352
[TBL] [Abstract][Full Text] [Related]
7. Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice.
Spanier JA; Fung V; Wardell CM; Alkhatib MH; Chen Y; Swanson LA; Dwyer AJ; Weno ME; Silva N; Mitchell JS; Orban PC; Mojibian M; Verchere CB; Fife BT; Levings MK
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37561596
[TBL] [Abstract][Full Text] [Related]
8. High-throughput sequencing reveals restricted TCR Vβ usage and public TCRβ clonotypes among pancreatic lymph node memory CD4(+) T cells and their involvement in autoimmune diabetes.
Marrero I; Aguilera C; Hamm DE; Quinn A; Kumar V
Mol Immunol; 2016 Jun; 74():82-95. PubMed ID: 27161799
[TBL] [Abstract][Full Text] [Related]
9. An Insulin-Inspired Supramolecular Hydrogel for Prevention of Type 1 Diabetes.
Liu M; Wang Z; Feng D; Shang Y; Li X; Liu J; Li C; Yang Z
Adv Sci (Weinh); 2021 May; 8(10):2003599. PubMed ID: 34026440
[TBL] [Abstract][Full Text] [Related]
10. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors.
D'Alise AM; Auyeung V; Feuerer M; Nishio J; Fontenot J; Benoist C; Mathis D
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19857-62. PubMed ID: 19073938
[TBL] [Abstract][Full Text] [Related]
11. Theoretical modeling reveals that regulatory T cells increase T-cell interaction with antigen-presenting cells for stable immune tolerance.
Yamaguchi T; Teraguchi S; Furusawa C; Machiyama H; Watanabe TM; Fujita H; Sakaguchi S; Yanagida T
Int Immunol; 2019 Oct; 31(11):743-753. PubMed ID: 31131864
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
Kishimoto TK; Fournier M; Michaud A; Rizzo G; Roy C; Capela T; Nukolova N; Li N; Doyle L; Fu FN; VanDyke D; Traber PG; Spangler JB; Leung SS; Ilyinskii PO
J Autoimmun; 2023 Nov; 140():103125. PubMed ID: 37844543
[TBL] [Abstract][Full Text] [Related]
13. B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice.
Henry-Bonami RA; Williams JM; Rachakonda AB; Karamali M; Kendall PL; Thomas JW
J Immunol; 2013 Jun; 190(12):5992-6003. PubMed ID: 23677466
[TBL] [Abstract][Full Text] [Related]
14. Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.
Feuerer M; Jiang W; Holler PD; Satpathy A; Campbell C; Bogue M; Mathis D; Benoist C
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18181-6. PubMed ID: 17991775
[TBL] [Abstract][Full Text] [Related]
15. Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation.
Verbeke CS; Gordo S; Schubert DA; Lewin SA; Desai RM; Dobbins J; Wucherpfennig KW; Mooney DJ
Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28116870
[TBL] [Abstract][Full Text] [Related]
16. Mapping of a hybrid insulin peptide in the inflamed islet β-cells from NOD mice.
Wenzlau JM; Peterson OJ; Vomund AN; DiLisio JE; Hohenstein A; Haskins K; Wan X
Front Immunol; 2024; 15():1348131. PubMed ID: 38455055
[TBL] [Abstract][Full Text] [Related]
17. Antigen-Specific Treg Therapy in Type 1 Diabetes - Challenges and Opportunities.
Serr I; Drost F; Schubert B; Daniel C
Front Immunol; 2021; 12():712870. PubMed ID: 34367177
[TBL] [Abstract][Full Text] [Related]
18. Imaging the emergence and natural progression of spontaneous autoimmune diabetes.
Mohan JF; Kohler RH; Hill JA; Weissleder R; Mathis D; Benoist C
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7776-E7785. PubMed ID: 28839093
[TBL] [Abstract][Full Text] [Related]
19. Improvement of Islet Engrafts via Treg Induction Using Immunomodulating Polymeric Tolerogenic Microparticles.
Neshat SY; Bauer SJ; Rhodes KR; Quiroz VM; Wong VW; Lowmaster SM; Tzeng SY; Green JJ; Doloff JC
ACS Biomater Sci Eng; 2023 Jun; 9(6):3522-3534. PubMed ID: 37233985
[TBL] [Abstract][Full Text] [Related]
20. Combining anti-IL-7Rα antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.
Vazquez-Mateo C; Collins J; Goldberg SJ; Lawson M; Hernandez-Escalante J; Dooms H
PLoS One; 2019; 14(3):e0214379. PubMed ID: 30908554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
